BioLife Solutions (NASDAQ:BLFS) reported quarterly sales of $44.26 million which beat the analyst consensus estimate of $43.28 million by 2.26 percent. This is a 18.64 percent increase over sales of $37.30 million the same period last year.
Novo Nordisk’s Wegovy Success Uplifts Denmark’s Economy And Reputation, But With Caution
Novo Nordisk A/S's (NYSE: NVO) remarkable success with its weight-loss treatment, Wegovy, is not only a cause for celebration but also a source of
